Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  androgen receptor antagonist TRC253
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
A Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 to 99
Trial IDs: 253PC101, NCI-2017-00114, NCT02987829
Start Over